QR kód

Universal vs. ASCO guidelines-based germline genetic testing for newly diagnosed breast cancer patients in resource-restricted settings

BackgroundA significant subset of breast cancer cases is attributable to inherited pathogenic genetic variants. Germline genetic testing (GGT), particularly for BRCA1 and BRCA2, represents a critical tool for precision oncology, enabling individualized risk stratification and the development of tail...

Celý popis

Uloženo v:
Hlavní autoři: Hikmat Abdel-Razeq, Faris Tamimi, Sarah Abdel-Razeq, Baha Sharaf, Hanan Khalil, Hira Bani Hani, Hala Abu-Jaish, Suhaib Khater, Lulwa El Saket, Tamer Al-Batsh, Marwa Sh Abrahim, Mohammad Sammour, Asem Mansour
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2026-01-01
Edice:Oncology Reviews
Témata:
germline genetic testing
GGT
breast cancer
BRCA1
BRCA2
resource-restrictedcountries
On-line přístup:https://www.frontiersin.org/articles/10.3389/or.2025.1638255/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky